<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02174588</url>
  </required_header>
  <id_info>
    <org_study_id>4-2012-0801</org_study_id>
    <nct_id>NCT02174588</nct_id>
  </id_info>
  <brief_title>Moderate Sedation for Elective Upper Endoscopy With Balanced Propofol Versus Propofol Alone: a Randomized Clinical Trial</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since introduction in 1989, propofol has gained wide acceptance for sedation during
      endoscopic procedures. The optimal sedation drug during esophagogastroendoscopy (EGD) is not
      established. Midazolam and propofol are used for sedation drug. Balanced propofol sedation
      (BPS) refers to the administration of an opiate, a benzodiazepine, and propofol. In this
      study, the investigators want to compare the patient satisfaction with EGD following balanced
      propofol sedation (BPS) versus propofol sedation alone.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 7, 2013</start_date>
  <completion_date type="Actual">February 4, 2015</completion_date>
  <primary_completion_date type="Actual">February 4, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>visual analog scale</measure>
    <time_frame>Within the 24 hours after EGD</time_frame>
    <description>The patient satisfaction with EGD following balanced propofol sedation (BPS) versus propofol sedation alone</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>complications rates</measure>
    <time_frame>Within the 1 hour after EGD</time_frame>
    <description>The recovery time after EGD following balanced propofol sedation versus propofol sedation alone. The safety after EGD following balanced propofol sedation versus propofol sedation alone</description>
  </secondary_outcome>
  <other_outcome>
    <measure>complications rates</measure>
    <time_frame>Within the 1 hour after EGD</time_frame>
    <description>The safety after EGD following balanced propofol sedation versus propofol sedation alone</description>
  </other_outcome>
  <other_outcome>
    <measure>total dose of the sedation drugs</measure>
    <time_frame>Within the 1 hour after EGD</time_frame>
    <description>The economy after EGD following balanced propofol sedation versus propofol sedation alone</description>
  </other_outcome>
  <other_outcome>
    <measure>visual analog scale</measure>
    <time_frame>Within the 1 hour after EGD</time_frame>
    <description>The endoscopist's satisfaction with EGD following balanced propofol sedation (BPS) versus propofol sedation alone</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>EGD Procedure</condition>
  <arm_group>
    <arm_group_label>balanced propofol group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>propofol alone group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam + propofol</intervention_name>
    <description>Midazolam and propofol are used for sedation drug. Balanced propofol sedation (BPS) refers to the administration of an opiate, a benzodiazepine, and propofol.</description>
    <arm_group_label>balanced propofol group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <description>propofol are used for sedation drug</description>
    <arm_group_label>propofol alone group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. over 19 years old, male and female

          2. patients who have plan to get esophagogastroduodenoscopy (EGD)

        Exclusion Criteria:

          1. ASA class III or IV

          2. Allergies to propofol, sulfites or eggs

          3. patients who had surgery for esophagus, stomach or duodenum

          4. inpatients

          5. patients who had sleep apnea, gastroparesis or achalasia

          6. patients who are taking sedative drugs more than 6 months

          7. pregnancy

          8. hypotension (systolic pressure less than 90mmHg), bradycardia (pulse rates less than
             50 times per minute) or hypoxia (SpO2 less than 90%)

          9. psychiatric or neurologic problems (ex. epilepsy or dementia)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Yonsei university College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2014</study_first_submitted>
  <study_first_submitted_qc>June 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2014</study_first_posted>
  <last_update_submitted>January 23, 2017</last_update_submitted>
  <last_update_submitted_qc>January 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sedation, propofol, midazolam</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

